— Latest update: May 2022 —
Digitalization is at the heart of Japan’s objectives for the future (Moonshot Program, Strategic Innovation Program). With Asia’s largest bioinformatics database located in Japan, the sector will be of an increasing importance, especially with its application to the medical and pharmaceutical industries.
How is Japanese biotech R&D structured, who are the key stakeholders, and how can European SMEs profit and find Japanese partners? Japan spends consistently over 3% of its GDP on R&D, of which some 70
This website and related activities are managed by the EU-Japan Centre for Industrial Cooperation, a joint venture between the European Commission's Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs (DG GROW) and the Japanese Government's Ministry of Economy, Trade & Industry (METI).
Hundreds of web pages with up-to-date information on Japan, more than 400 market reports and recorded webinars available as well as a lot of detailed information on Japanese business culture.